Burke William P. Mr. 4
4 · Axogen, Inc. · Filed Nov 13, 2025
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Burke William P. Mr.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-10$8.14/sh+19,227$156,508→ 19,327 total - Sale
Common Stock
2025-11-11$24.02/sh−3,591$86,249→ 100 total - Sale
Common Stock
2025-11-10$24.01/sh−19,227$461,640→ 100 total - Exercise/Conversion
Common Stock
2025-11-11$8.14/sh+3,591$29,231→ 3,691 total - Exercise/Conversion
Stock Option (right to purchase)
2025-11-10−19,227→ 3,591 totalExercise: $8.14Exp: 2032-07-11→ Common Stock (19,227 underlying) - Exercise/Conversion
Stock Option (right to purchase)
2025-11-11−3,591→ 0 totalExercise: $8.14Exp: 2032-07-11→ Common Stock (3,591 underlying)
Footnotes (3)
- [F1]The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.10 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.13 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022.